- Intramuscular Injection
- Intravenous Injection
Asia Pacific Oxytocic Pharmaceuticals Market size was valued at USD x billion in 2021 and is expected to reach USD x billion by 2028, at a CAGR of x% during the forecast period 2022 to 2028. Oxytocin is a female reproductive hormone secreted in the hypothalamus and released into blood circulation during childbirth to induce the labor and milk production in mothers. It is also used as uterotonic (induce uterine contractions) and reduce the hemorrhage after C-section. Increase in the number of female population in India and China, rise in awareness about the oxytocin usage, and escalation in complicated pregnancies are anticipated to boost the asia pacific oxytocic pharmaceuticals market over the forecast years.
Fastest Growing Market
The Adverse effects associated with oxytocic drugs and lack of awareness in underdeveloped countries may restrain the growth of Asia Pacific oxytocic pharmaceuticals market over the forecast period.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.